Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

204
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
204
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

517
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
517
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

266
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
266
Positron Emission Tomography01:29

Positron Emission Tomography

6.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.3K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

275
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
275
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

1.6K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avatar: Personalized Precision Radio-Genomic Theranostic Oncology.

Cancer biotherapy & radiopharmaceuticals·2025
Same author

Intuitive Human-Artificial Intelligence Theranostic Complementarity.

Cancer biotherapy & radiopharmaceuticals·2025
Same author

Human-Artificial Intelligence Symbiotic Reporting for Theranostic Cancer Care.

Cancer biotherapy & radiopharmaceuticals·2024
Same author

Theranostics, Advanced Cancer, and The Meaning of Life.

Cancer biotherapy & radiopharmaceuticals·2024
Same author

Theranostics: Timing is Everything.

Cancer biotherapy & radiopharmaceuticals·2024
Same author

Theranostic Innovation by Humane N-of-One Cancer Care in Real-World Patients.

Cancer biotherapy & radiopharmaceuticals·2024

Related Experiment Video

Updated: Oct 26, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.6K

Responsible Radionuclide Cancer Care.

J Harvey Turner1

  • 1Department of Nuclear Medicine, The University of Western Australia, Fiona Stanley Fremantle Hospitals, Murdoch, Australia.

Cancer Biotherapy & Radiopharmaceuticals
|August 2, 2021
PubMed
Summary

Nuclear oncology is evolving with molecular theranostics and AI, expanding physician roles in cancer care. This requires new knowledge and ethical considerations for targeted radionuclide diagnosis and therapy.

Keywords:
accountabilityartificial intelligencemultidisciplinary tumor board responsibilitypersonalized dosimetryphronesistheranostics

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.2K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

Related Experiment Videos

Last Updated: Oct 26, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.6K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.2K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

Area of Science:

  • Nuclear oncology
  • Molecular imaging and therapy
  • Medical ethics

Background:

  • The field of nuclear oncology is undergoing rapid transformation.
  • Emerging technologies are significantly broadening the scope of physician responsibilities.
  • The integration of new diagnostic and therapeutic modalities presents complex challenges.

Purpose of the Study:

  • To explore the evolving responsibilities of physicians in nuclear oncology.
  • To discuss the impact of new technologies on cancer care delivery.
  • To examine the ethical and practical considerations of molecular radionuclide theranostics.

Main Methods:

  • Review of current advancements in nuclear oncology.
  • Analysis of the integration of artificial intelligence and radiomics.
  • Discussion of pharmacogenomics and regulatory requirements for dosimetry.

Main Results:

  • Molecular radionuclide theranostics are redefining cancer diagnosis and treatment.
  • Multidisciplinary approaches and AI are enhancing diagnostic accuracy.
  • Pharmacogenomics and individualized dosimetry are improving treatment prediction and safety.

Conclusions:

  • Physicians face expanding responsibilities due to technological advancements in nuclear oncology.
  • Mastering new technologies necessitates a growing knowledge base and ethical awareness.
  • The evolving role of the nuclear physician in shared patient care requires transparency and accountability in targeted radionuclide therapy.